EE+ POEM Archive
Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Monoclonal Antibodies for Alzheimer Disease: a Lack of Clinically Meaningful Benefits, Plus Significant Harms." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377066/all/Monoclonal_antibodies_for_Alzheimer_disease:_A_lack_of_clinically_meaningful_benefits__plus_significant_harms.
Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377066/all/Monoclonal_antibodies_for_Alzheimer_disease:_A_lack_of_clinically_meaningful_benefits__plus_significant_harms. Accessed December 8, 2024.
Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms. (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377066/all/Monoclonal_antibodies_for_Alzheimer_disease:_A_lack_of_clinically_meaningful_benefits__plus_significant_harms
Monoclonal Antibodies for Alzheimer Disease: a Lack of Clinically Meaningful Benefits, Plus Significant Harms [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377066/all/Monoclonal_antibodies_for_Alzheimer_disease:_A_lack_of_clinically_meaningful_benefits__plus_significant_harms.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms
ID - 3377066
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377066/all/Monoclonal_antibodies_for_Alzheimer_disease:_A_lack_of_clinically_meaningful_benefits__plus_significant_harms
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
